The Patent Finder

Diabetomics, Inc.

10 patents currently held · Updated Nov 18, 2026
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
5
Ending by 2030
Sep 2029
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

No maintenance fee falls due on this company's record before Nov 18, 2027.

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 10 of 10

PatentTitleStatus Expires Confidence
US 8,476,008Methods for detecting pre-diabetes and diabetes
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,168,396Methods for detecting pre-diabetes and diabetes using differential protein glycosylation
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,497,076Methods for detecting pre-diabetes and diabetes using differential protein glycosylation
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,497,077Methods for detecting pre-diabetes and diabetes using differential protein glycosylation
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,530,175Methods for detecting pre-diabetes and diabetes using differential protein glycosylation
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,852,873Maternal biomarkers for gestational diabetes
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,975,034Maternal Biomarkers for Gestational Diabetes
In force
 · Medium confidence
In forceMedium confidence
US 9,383,370Maternal biomarkers for gestational diabetes
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,383,352Salivary protein glycosylation test for diagnosis and monitoring of diabetes
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,996,228Biomarkers for assessment of preeclampsia
In force
 · From the USPTO record
In forceFrom the USPTO record
Also on record, not counted in the 10: 1 patent in force now held by others. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited